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INTRODUCTION
Cavernous hemangioma of the liver is the most
common benign neoplasm (1). Cavernous heman-
gioma usually presents as solitary well-delineated,
subcapsular, and disclosed nodules, and these dis-
tinctive structures show a characteristic hemody-
namic pattern on enhanced computed tomography
(CT). However, it was already reported that some
cases contain parts of hyaline degeneration, secon-
dary to thrombus, necrosis, or cicatrization, mim-
icking the hepatic malignancies such as metastatic
liver tumor or cholangiocarcinoma (2). A hepatic
sclerosed hemangioma is the ultimate form having
all these degenerative changes (3). We report herein
a case of such a rare hepatic tumor, sclerosed he-
mangioma, which was misdiagnosed as a liver me-
tastasis of gastric cancer.
CASE REPORT
A 75 years old male was referred to our institute
for gastric cancer and a hepatic space occupied le-
sion (SOL). He had visited an affiliated hospital of
our university for routine examination of prostatic
hyperplasia, and was pointed out anemia. For fur-
ther examinations, he took gastroscopy and there
was type 3 tumor at posterior wall of gastric angle
(Fig 1a). Biopsied specimens were diagnosed as
well differentiated adenocarcinoma (tub1). Gastric
fluoroscopy showed tumor and induration of lesser
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curvature (Fig 1b). Enhanced CT showed a small
mass in segment 8 of the liver, and this hepatic SOL
was suspected to be metastasis of gastric cancer.
The initial laboratory data were as follows :
5300 /μl white blood cell count, 7.8 g/dL hemoglo-
bin, 430,000 /μl platelet count, 19 IU/L aspartate
aminotransferase, 13 IU/L alanine aminotransferase,
11 mg/dL blood urea nitrogen, 0.87 mg/dL cre-
atinin, 3.7 g/dL albumin. Tumor markers were as
follows : 7 ng/mL alpha-fetoprotein, 1.7 ng/mL car-
cinoembryonic antigen (CEA), and 38 U/mL carbo-
hydrate antigen (CA) 19-9. He was positive for hepa-
titis B (HB) surface antibody (HBsAb), HBeAb and
HBcAb, and negative for HBsAg and HBeAg.
Plain CT showed a low density mass, 1.11.0
cm in size, in segment 8 of the liver. Enhanced CT
showed that the mass lesion was gradually enhanced
mainly in the marginal border between normal pa-
renchyma and SOL, and the mass was not enhanced
compared to parenchyma (iso-density) in the de-
layed phase (Fig 2). Magnetic resonance imaging
(MRI) showed that the tumor had a low signal on
T1-weighted and high signal on T2-weighted im-
ages. Hepatobiliary phase of ethoxybenzyl (EOB)-
enhanced MRI showed no uptake in the correspond-
ing area, as a defect (Fig 3). Fluoro-deoxy-glucose
positron emission tomography (FDG-PET) showed
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Figure 2 : Abdominal computed tomography. (a) Plain CT. (b)
Contrast CT, early phase. (c) Contrast CT delayed phase. Arrows
indicate the tumor.
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c
Figure 3 : Abdominal magnetic resonance imaging. (a) MRI, T1-
weighted image. (b) MRI, T2-weighted image. (c) EOB en-
hanced MRI, hepatocyto phase. Arrows indicate the tumor.
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Figure 1 : Gastric examinations. (a) findings of gastroscopy.
There is type 3 tumor at posterior wall in gastric angle. The his-
tological examination revealed the tumor to be well differentiated
adenocarcinoma (tub1). (b) findings of Gastric fluoroscopy. This
shows tumor and induration of the lesser curvature.
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that FDG accumulated only in gastric tumor (SUV-
max 6.8). With these findings, we diagnosed the
liver mass as metastasis of gastric cancer (Stage IV).
In this case, chemotherapy is recommended accord-
ing to gastric cancer treatment guideline. However,
we performed distal gastrectomy in order to con-
trol the bleeding from gastric cancer.
Operative fingngs and resected specimens
With fully informed consents for a possible he-
patic malignant tumor, we performed distal gastrec-
tomy. The edge of the liver was sharp, and liver sur-
face was smooth. As intraoperative echography re-
vealed that the liver mass of segment 8 was near the
liver surface, wedge resection of segment 8 of the
liver was also performed. The resected specimen of
the liver showed a well demarcated homogenous
white solid mass, 0.80.7 cm in size, elastic hard
(Fig 4). Histrogical examinations showed that most
area comprised hyalinized tissue and collagen fibers
with small and thin-walled vascular space (Fig 5a).
Immunohistochemical staining revealed some vas-
cular components, as shown by positive CD34 in its
peripheral region (Fig 5b). Masson’s trichrome
stain highlighted the sclerotic condition of the mass
a
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Figure 4 : Macroscopic findings of the resected tumor. The tu-
mor was a well -demarcated homogenous white solid nodule,
0.80.7 cm in size. (a) resected specimen. (b) after formalin
preservation.
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Figure 5 : Microscopic findings of the resected tumor. The tu-
mor was composed of fibrous connective tissue and various sizes
of cavernous hemangioma tissue, HE staining (a), CD34 positive
vascular components (b), Sclerosis is highlighted with collagen
fiber, Masson’s trichrome (c).
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(Fig 5c). From these characteristics, the tumor was
finally diagnosed as a hepatic sclerosed heman-
gioma. Final diagnosis of gastric cancer was T3(ss),
N2, ly2, v1, M0 (Stage IIIb).
DISCUSSION
Cavernous hemangioma of the liver is the most
frequent, the reported incidence being as high as
20% in liver tumor (4). The high incidence of he-
mangioma increases the probability of encounter-
ing atypical manifestations, including necrosis, scar-
ring, and calcification. A sclerosed hemangioma is
the ultimate form having all these degenerative
changes, and such varaeties of pathological charac-
teristics make precisely radiological diagnosis very
difficult (5).
In our case, plain CT showed hepatic screlosed
hemanangioma as low density, and enhanced CT
showed a ring enhancement pattern, which is char-
acteristic of adenocarcinoma. Although cavernous
hemangioma shows typical features : low density on
plain CT and delayed pooling enhancement, many
previous reports have not shown this feature in scle-
rosed hemangioma (5-12). MRI finding in our case
was fit to typical feature of cavernous hemangioma,
such as low on T1 and high on T2 weighted images,
but this feature can be also observed in the cases
of metastatic liver tumors and cholangiocellular car-
cinoma. Others also reported that MRI findings of
sclerosed hemangioma were different from the typi-
cal cavernous hemangioma (5-11). It was reported
that nodular areas of reduced signal intensity on T2-
weighted images corresponded to the histological
finding of fibrosis (13). A complicating factor is the
contribution to signal heterogeneity of hemorrhage,
thrombosis, hyalinization, calcification, and cystic
cavities (13). On the otherhand, in our case, FDG
accumulated only in gastric tumor, not in hepatic
tumor in FDG-PET scan. However, the size of he-
patic tumor was so small that this finding could not
eliminate the malignancy. With the fact that there
was advanced gastric cancer and these radiological
findings, metastatic liver tumor from gastric cancer
could not be excluded. It has reported that the find-
ings such as geographical pattern, capsular-retrac-
tion, decrease in size in follow-ups, and vanishing
of previous enhanced lesion should raise the pos-
sibility of the presence of screlosed hemangioma,
and it can be diagnosed with biopsy before surgi-
cal intervention (5). However, we do not agree the
universal application of perctaneous needle biopsy
to make a definite diagnosis of hepatic tumor such
as present case. Becouse a percutaneous biopsy has
been reported to have a potential risk of abdomi-
nal dissemination by needle tract implantation (14).
As hepatic resection has been safe procedure in re-
cent years (15, 16), hepatic resection should be cho-
sen as a first strategy for tumors with unknown
pathologically malignant potential.
Although sclerosed hemangioma is a rare disease
among hepatic tumors, it needs to be taken into con-
sideration among differential diagnosis of hepatic tu-
mors. As it was extremely difficult to differentiate
the lesion from liver metastasis or cholangiocellar-
carcinoma, if the malignancy of the tumor cannot
be denied, hepatic resection should be chosen for
diagnostic therapy.
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